Mostrando 1 - 20 Resultados de 35 Para Buscar '"GlaxoSmithKline"', tiempo de consulta: 0.13s Limitar resultados
  1. 1
    The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
    “... Kimberly Adkison7 1GlaxoSmithKline, Research Triangle Park, NC, USA; 2UNC Eshelman School of Pharmacy...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  2. 2
    An indirect comparison of HbA1c treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method
    por Martin AA, Parks D
    Publicado 2016
    “...Alan A Martin,1 Daniel Parks2 1Department of Value Evidence Analytics, GlaxoSmithKline, Uxbridge...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  3. 3
    Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials
    por Yang F, Ye J, Pomerantz K, Stewart M
    Publicado 2013
    “..., GlaxoSmithKline, King of Prussia, PA, 2Discovery Biometrics, GlaxoSmithKline, Research Triangle Park, NC, 3...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  4. 4
    Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study
    por Tompson DJ, Crean CS, Buraglio M, Arumugham T
    Publicado 2014
    “... Modelling and Simulation, GlaxoSmithKline, Stevenage, Hertfordshire, UK; 2Clinical Pharmacology...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  5. 5
    Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
    “...Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USA; 2Value Evidence and Outcomes...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  6. 6
    Transparencia en la investigación biomédica: A propósito de los riesgos asociados al uso de Avandia
    por SALAS,SOFÍA P, RUSSO,MOISÉS
    Publicado 2010
    “... risks associated with the use of Avandia, a rosiglitazone produced by Glaxo Smith Kline. In fact...”
    Enlace del recurso
    Agregar a favoritos
    Guardado en:
  7. 7
    Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
    por Han MK
    Publicado 2021
    “... from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Merck, Mylan and Novartis. She also reports...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  8. 8
    Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
    por Yang F, Stewart M, Ye J, DeMets D
    Publicado 2015
    “...GlaxoSmithKline, Upper Merion, PA, USA; 3Department of Biostatistics and Medical Informatics, University...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  9. 9
    Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
    “... Aviv University, Tel Aviv, Israel; 2GlaxoSmithKline, Collegeville, PA, USAAbstract: Lapatinib...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  10. 10
    Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
    por Yardley DA
    Publicado 2019
    “...: Novartis, Janssen, Roche/Genentech, Bristol-Myers Squibb, Amgen, Celgene, Eli Lilly, GlaxoSmithKline...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  11. 11
    Vacunas anti-rotavirus: Al fin una realidad
    por O'Ryan G,Miguel
    Publicado 2005
    “... más de 60.000 niños. Estas dos vacunas, Rotarix® de Glaxo SmithKline Biologicals y Rotateq® de Merck...”
    Enlace del recurso
    Agregar a favoritos
    Guardado en:
  12. 12
    Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics.
    “... (Bexsero, GlaxoSmithKline) on reducing oropharyngeal carriage of Neisseria meningitidis (Nm) in 34,489...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  13. 13
    Target prediction for an open access set of compounds active against Mycobacterium tuberculosis.
    “... GlaxoSmithKline published the results of a high-throughput screen (HTS) of their two million compound library...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  14. 14
    Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets
    “... compounds from the GlaxoSmithKline TB-set. We have established and utilized novel previously unexplored host...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  15. 15
    Oral rotavirus vaccine shedding as a marker of mucosal immunity
    “... live-attenuated, oral rotavirus vaccine (Rotarix, GlaxoSmithKline) efficacy trial conducted among...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  16. 16
    PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor
    “... distributed to more than 300 laboratories by GlaxoSmithKline (GSK) between 2011 and 2015 and by SGC-UNC from...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  17. 17
    Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)
    “... vaccine (Engerix-B®, or Twinrix®, GlaxoSmithKline). Anti-HBs titers were measured at 1–3 months post third...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  18. 18
    Análisis crítico de un artículo: La rosiglitazona aumenta los eventos cardiovasculares a largo plazo
    “... failure, and cardiovascular mortality. Data sources: We searched MEDLINE, the GlaxoSmithKline clinical...”
    Enlace del recurso
    Agregar a favoritos
    Guardado en:
  19. 19
    Glial and endothelial blood-retinal barrier responses to amyloid-β in the neural retina of the rat
    “..., UK; 3Neurosciences, Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, Harlow...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
  20. 20
    The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients
    por Koshino Y, Bahk WM, Sakai H, Kobayashi T
    Publicado 2013
    “... (Neurosciences), Development and Medical Affairs, GlaxoSmithKline, Shibuya, Tokyo, Japan Abstract: This study...”
    Enlace del recurso
    article
    Agregar a favoritos
    Guardado en:
Herramientas de búsqueda: RSS — Enviar por Correo electrónico esta Búsqueda — Guardar Búsqueda